Latest news
Low Tumor PD-L1 Expression Identifies Responders to Neoadjuvant Leukocyte Interleukin Injection in Locally Advanced HNSCC - OncLiveOncLive · Tue, 04 Aug 2026 07:00:00 GMTFDA Grants Priority Review to Subcutaneous Amivantamab for Advanced HNSCC - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 20:09:42 GMT